A licence limit that shaped a fuel market
The commercial arrival of LEU+ in the United States rests on a regulatory decision made more than a year earlier. In September 2025, the US Nuclear Regulatory Commission authorised Urenco USA to enrich uranium up to 10% U-235 at its National Enrichment Facility in Eunice, New Mexico. That approval lifted the ceiling that had confined US commercial centrifuge output to the traditional 5% U-235 boundary separating low-enriched uranium from higher-assay material.
With the authorisation in place, existing infrastructure holds operating licences covering all of the site's gas centrifuge cascades, allowing production volume to be adjusted to commercial contract specifications. The result is a supply chain that can respond to customer demand rather than to a single fixed product specification.
Why the 10% threshold matters for HALEU
The regulatory ceiling is directly relevant to high-assay low-enriched uranium, which contains 10%-20% U-235 and is the fuel form required by several advanced reactor technologies under development. LEU+ in the 5%-10% band can serve as feedstock for producing HALEU, creating a domestic upstream step for material that has historically been scarce outside Russia.
Not every advanced reactor needs HALEU. Some designs will run directly on LEU+, which means the same NRC authorisation supports two distinct customer segments: existing light water reactors seeking longer operating cycles, and new reactor developers with different enrichment requirements.
Operating benefits cited for conventional plants
For the existing fleet, the case for LEU+ is economic rather than strategic. Higher enrichment supports extended operating cycles between refuelling outages, reducing maintenance costs and improving annual plant factor. Urenco has framed the product as a way to extract more output from reactors that are already built and licensed.
Regulation as the pacing item
The sequence illustrates how licensing, not centrifuge capacity alone, sets the tempo of fuel innovation. Urenco's cascades existed before the authorisation; the material could not be commercially produced at those assays until the regulator agreed. The same pattern is visible downstream, where fuel qualification and irradiation testing campaigns now gate the deployment of HALEU-bearing fuels.
The September 2025 approval allowed industrial enrichment up to the 10% concentration limit, enabling commercial LEU+ output.
For buyers, the practical question shifts from whether higher-assay enrichment is permitted in the United States to how quickly volume can be contracted and delivered under the new limit.
This article was assisted by AI analysis. Please refer to the original source for official information.